Table 2.

Immune-related adverse events in patients with TET and NSCLC.

	TET (n = 31)		NSCLC (n = 60)
Immune-related adverse events	Grade 1/2	Grade ≥ 3	Grade 1/2	Grade ≥ 3
Hepatitis	0 (0)	3 (9.7)	2 (3.2)	1 (1.7)
Myasthenia gravis	1 (3.2)	1 (3.2)	0 (0)	0 (0)
Myocarditis	0 (0)	2 (6.5)	0 (0)	0 (0)
Hypothyroidism	3 (9.7)	1 (3.2)	3 (5.0)	2 (3.2)
Colitis	0 (0)	1 (3.2)	1 (1.7)	0 (0)
Nephritis	1 (3.2)	1 (3.2)	0 (0)	0 (0)
Subacute myoclonus	0 (0)	1 (3.2)	0 (0)	0 (0)
Pneumonitis	6 (19.4)	0 (0)	1 (1.7)	3 (5.0)
Pruritis	4 (12.9)	0 (0)	11 (18.3)	0 (0)
Rash	4 (12.9)	1 (3.2)	8 (13.3)	0 (0)
Arthritis	1 (3.2)	0 (0)	0 (0)	0 (0)
Sensory neuropathy	2 (6.5)	0 (0)	0 (0)	0 (0)
Fever	1 (3.2)	0 (0)	0 (0)	0 (0)